Shopping Cart
- Remove All
- Your shopping cart is currently empty
(S)-CCG-1423 is a stereoisomer of CCG-1423. CCG-1423 is a Rho inhibitor involved in blocking signaling through myocardin-related transcription factor A and serum response factor.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $263 | Backorder | |
10 mg | $500 | Backorder |
Description | (S)-CCG-1423 is a stereoisomer of CCG-1423. CCG-1423 is a Rho inhibitor involved in blocking signaling through myocardin-related transcription factor A and serum response factor. |
In vitro | CCG-14223 was an inhibitor for Rho/SRF pathway and displayed activity in several in vitro cancer cell functional assays. In PC-3 prostate cancer cells, CCG-1423(< 1 μmol/L) potently inhibited lysophosphatidic acid-induced DNA synthesis. CCG-1423 inhibited the growth of RhoC-overexpressing melanoma lines at nanomolar concentrations. CCG-1423 selectively stimulated apoptosis of the metastasis-prone, RhoC-overexpressing melanoma cell line when compared with the parental cell line. CCG-1423 inhibited Rho-dependent invasion by PC-3 prostate cancer cells. The S-isomer of CCG-1423 inhibited MRTF-A-dependent cellular events, including SRF-mediated gene expression and cell migration. The efficacy of (S)-CCG-1423 was more potent than the R-isomer [1][2]. |
Molecular Weight | 454.8 |
Formula | C18H13ClF6N2O3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | Ethanol: ≤0.25 mg/mL DMSO: 10 mg/mL |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.